TrojanBio
Latest round
- Seed
Last raised
- Dec 2023
Total raised
- Undisclosed
Investors
- 1
About TrojanBio
Founded in 2021 and based in Ness Ziona, Israel, TrojanBio Ltd. operates as a pre-clinical immunotherapy company that engages in developing therapeutic antibodies for the treatment of cancers. Anat Burkovitz (CEO), Amir Aharoni, and Noam Diamant are the co-founders of the company. In January 2022, TrojanBio Ltd. The company offers a Trojan platform, which is an AI-driven antibody solution that presents an approach to combating a wide spectrum of cancer types by harnessing the power of viral-specific immunity. The firm’s product includes a Trojan bi-specific antibody that comprises two essential modules: a cancer-targeting module and a viral immunity activation module. This combination allows the antibody to target cancer cells and label them as virally infected cells, activating the anti-viral immunity mechanism to combat cancer. TrojanBio’s pipeline includes TRJ-E84, an anti-EGFR-CMV peptide Trojan antibody for colon cancer treatment; TRJ-T75, designed to combat triple-negative breast cancer (TNBC) by targeting Trop2-CMV peptides; and TRJ-103, which hold the potential to further expand the company's therapeutic offerings.
Who invested in TrojanBio
1 investor across 2 rounds
See all investors in TrojanBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about TrojanBio
Who invested in TrojanBio?
TrojanBio has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TrojanBio raised?
TrojanBio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did TrojanBio last raise money?
TrojanBio's most recent round on record is a Seed, in Dec 2023.
What does TrojanBio do?
Founded in 2021 and based in Ness Ziona, Israel, TrojanBio Ltd.
Where is TrojanBio headquartered?
TrojanBio is headquartered in Ness Ziona, Israel.
Which VCs invest in companies like TrojanBio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at TrojanBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like TrojanBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.